Wales Health Services Now Offers Prescription Cannabis-Based Drug for MS
The NHS of Wales in the UK has just become the first NHS in the UK to fund cannabis-based medicine for people with multiple sclerosis.
Topic
sativex
9 articles
Cannabis May Treat Lou Gehrig’s Disease
New research shows marijuana-based treatments could delay the progression of a fatal condition known as Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS).
Law & PoliticsLink
France’s Ministry of Health Approves Cannabis-Based Sativex Medicine
France’s ministry of health announced Thursday that it has approved Sativex, a cannabis-based mouth spray produced by GW pharmaceutricals. Sativex will be available in
Cannabis FactsLink
Real Cannabis More Effective Than Cannabis Pharmaceuticals
An international study found that real cannabis is more effective for patients than cannabis pharmaceuticals.
GW Pharmaceuticals, Legal Marijuana Monopoly, Launches Sativex Spray in Italy
GW Pharmaceuticals has launched their Sativex cannabis extract spray in Italy for use by Multiple Sclerosis (MS) patients.
Marijuana-Based Medicines Okayed in France
France has modified its Public Health Code to allow for the use of marijuana-based medicines, apparently including raw marijuana itself.
CannabusinessLink
The Original Marijuana Stock Files for US IPO
GWP, the maker of Sativex and undeniably the original marijuana stock files for U.S. IPO
Law & PoliticsLink
France Considers Marijuana-based Drug for Muscle Pain
The French government is considering legalizing Sativex, a marijuana-based spray for muscle pain, such as people with multiple sclerosis.
